Clinical Trial: An exploratory study on the efficacy and safety of golidocitinib combined with azacitidine in the treatment of elderly patients with newly diagnosed AITL (China)

China, Aug. 26 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'An exploratory study on the efficacy and safety of golidocitinib combined with azacitidine in the treatment of elderly patients with newly diagnosed AITL'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600130794

Registration Time: 2026/08/25

Type: Interventional study

Primary Sponsor: The FIrst Affiliated Hospital, College of Medicine, Zhejiang University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=310787

Published by HT Digital Content Services with permission from Health Daily Digest....